Related Experiment Videos
Serologic testing for inflammatory bowel disease.
E J Hoffenberg1, S Fidanza, A Sauaia
1Center for Pediatric Inflammatory Bowel Diseases, Section of Pediatric Gastroenterology, University of Colorado School of Medicine, Denver, USA.
The Journal of Pediatrics
|April 6, 1999
Summary
Anti-neutrophil cytoplasmic antibodies (ANCAs) and anti-Saccharomyces cerevisiae antibodies (ASCA) show promise in diagnosing pediatric inflammatory bowel disease. Together, these antibodies help differentiate ulcerative colitis from Crohn's disease in children.
Area of Science:
- Pediatric gastroenterology
- Immunology
- Inflammatory bowel disease diagnostics
Background:
- Distinguishing inflammatory bowel disease (IBD) from other pediatric gastrointestinal disorders is crucial.
- Accurate differentiation between ulcerative colitis (UC) and Crohn's disease (CD) is essential for appropriate treatment.
Purpose of the Study:
- To evaluate the diagnostic accuracy of anti-neutrophil cytoplasmic antibodies (ANCAs) and anti-Saccharomyces cerevisiae antibodies (ASCA) in pediatric IBD.
- To assess the utility of ANCAs and ASCA in differentiating UC from CD in children.
Main Methods:
- Serum samples from 120 children (74 controls, 25 UC, 20 CD) were tested for IgG ANCAs and IgA/IgG ASCA.
- Blinded analysis was performed to determine the presence of these antibodies.
Main Results:
- Combined ANCAs and ASCA achieved 71% sensitivity for detecting IBD.
- ANCAs demonstrated 80% sensitivity for UC, with high-titer ANCAs being UC-specific.
- ASCA were found to be specific for CD.
Conclusions:
- While not sensitive enough for population screening, combined ANCA and ASCA testing can aid in evaluating pediatric IBD.
- These antibodies are valuable tools for distinguishing between UC and CD in children.